These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clostridium difficile infection is associated with graft loss in solid organ transplant recipients. Cusini A; Béguelin C; Stampf S; Boggian K; Garzoni C; Koller M; Manuel O; Meylan P; Mueller NJ; Hirsch HH; Weisser M; Berger C; van Delden C; Am J Transplant; 2018 Jul; 18(7):1745-1754. PubMed ID: 29349869 [TBL] [Abstract][Full Text] [Related]
9. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population. Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741 [TBL] [Abstract][Full Text] [Related]
10. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study. Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296 [TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile infection in the intensive care unit. Riddle DJ; Dubberke ER Infect Dis Clin North Am; 2009 Sep; 23(3):727-43. PubMed ID: 19665092 [TBL] [Abstract][Full Text] [Related]
12. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. El Feghaly RE; Stauber JL; Deych E; Gonzalez C; Tarr PI; Haslam DB Clin Infect Dis; 2013 Jun; 56(12):1713-21. PubMed ID: 23487367 [TBL] [Abstract][Full Text] [Related]
13. The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients. Sullivan T; Weinberg A; Rana M; Patel G; Huprikar S Transplantation; 2016 Sep; 100(9):1939-43. PubMed ID: 27379554 [TBL] [Abstract][Full Text] [Related]
17. Lack of Benefit With Combination Therapy for Clostridium difficile Infection. Njoku JC; Van Schooneveld TC; Rupp ME; Olsen KM; Qiu F; Meza JL; Hermsen ED Infect Control Hosp Epidemiol; 2017 May; 38(5):602-605. PubMed ID: 28162100 [TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Clostridium Difficile Diarrhea in Patients With Solid Organ Transplantation. Ramos A; Ortiz J; Asensio Á; Martínez-Ruiz R; Múñez E; Cantero M; Cozar A; Ussetti P; Portolés J; Cuervas-Mons V Prog Transplant; 2016 Sep; 26(3):231-7. PubMed ID: 27358344 [TBL] [Abstract][Full Text] [Related]
19. Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study. Fischer M; Kao D; Mehta SR; Martin T; Dimitry J; Keshteli AH; Cook GK; Phelps E; Sipe BW; Xu H; Kelly CR Am J Gastroenterol; 2016 Jul; 111(7):1024-31. PubMed ID: 27185076 [TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study. Nguyen CT; Li J; Anders S; Garcia-Diaz J; Staffeld-Coit C; Hand J Transpl Infect Dis; 2018 Jun; 20(3):e12867. PubMed ID: 29512244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]